Life Spine Announces FDA 510(k) Clearance for the PLATEAU®-A Ti Anterior Lumbar Spacer System

August 05, 2020 

HUNTLEY, Ill.–(BUSINESS WIRE)–Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that it has received clearance from the U.S. Food & Drug Administration (FDA) to market the PLATEAU-A Ti Anterior Lumbar Spacer System.

“With the increased usage of anterior column reconstruction, PLATEAU-A Ti fills an important portfolio gap. Joining our recently launched DYNA-LINK® Titanium Stand-Alone ALIF Spacer System and SENTRY® ALIF Plating System, this clearance expands our robust ALIF portfolio,” said Rich Mueller, Chief Operating Officer for Life Spine. “Continuing our success with previous interbody technologies, PLATEAU-A Ti provides surgeons with a titanium implant available in a variety of heights, widths, and lordotic options.”

PLATEAU-A Ti Anterior Lumbar Spacer System is a comprehensive system that can be used for anterior fusion procedures. Multiple footprint sizes are available in various heights to accommodate individual patient anatomies and pathologies to promote fusion.

Key Features and Benefits:

  • Large, open graft windows for maximum visibility and bone graft containment
  • Osseo-Loc™ Surface Treatment Technology
  • Chamfered leading edge to ease implant insertion

About Life Spine

Life Spine is dedicated to improving the quality of life for spinal patients by increasing procedural efficiency and efficacy through innovative design, uncompromising quality standards, and the most technologically advanced manufacturing platforms. Life Spine, which is privately held, is based in Huntley, Illinois. For more information, please visit: and/or


Mr. Omar Faruqi
Chief Financial Officer

Print Friendly, PDF & Email

Chris J. Stewart

Chris currently serves as President and CEO of Surgio Health. Chris has close to 20 years of healthcare management experience, with an infinity to improve healthcare delivery through the development and implementation of innovative solutions that result in improved efficiencies, reduction of unnecessary financial & clinical variation, and help achieve better patient outcomes. Previously, Chris was assistant vice president and business unit leader for HPG/HCA. He has presented at numerous healthcare forums on topics that include disruptive innovation, physician engagement, shifting reimbursement models, cost per clinical episode and the future of supply chain delivery.

Related Articles

Back to top button